Xanthoma Planum.
Little EG.
Proc R Soc Med. 1909;2(Dermatol Sect):74.
Development of systemic sarcoidosis and xanthoma planum during multiple sclerosis treatment with interferon-beta 1a: Case Report.
Viana de Andrade AC, Brito ÉA, Harris OM, Viana de Andrade AP, Leite MF, Pithon MM.
Int J Dermatol. 2015;54(5):e140-5. doi: 10.1111/ijd.12676. Epub 2014 Sep 10.
[Diffuse normolipemic xanthoma planum].
Carapeto FJ, Coscojuela C, Martin J, Simal E, Giner E.
Med Cutan Ibero Lat Am. 1988;16(3):205-10.
[Normolipemic xanthoma planum and its associated syndromes].
Winkelmann RK.
Hautarzt. 1983 Apr;34(4):159-63.
[Xanthoma planum with normal lipidemia and paraproteinemia].
Perrault M, Duperrat B, Dry J, Courmont J.
Ann Med Interne (Paris). 1971 Jun-Jul;122(6):799-805.
Xanthoma disseminatum (also tuberosum et planum).
DOWNING JG.
Arch Derm Syphilol. 1947 Mar;55(3):405.
[Xanthoma planum gangraenosum in the course of multiple myeloma].
Nowak A, Kadyków M, Strokowska M.
Przegl Dermatol. 1979 Sep-Oct;66(5):525-30.
[Lysozyme-positive cells and ultrastructural findings in granulomatous and histiocyte-proliferative skin diseases].
Shimada K.
Nihon Hifuka Gakkai Zasshi. 1989 Feb;99(2):101-10.
[Normocholesteremic generalized cutaneous xanthomatosis planum in a patient with Waldenstroem's macroglobulinemic lymphoreticulosis].
Rabbiosi G, Bernasconi C.
Minerva Dermatol. 1967 Dec;42(12):666-7.
[Hypocomplementemia of the first fractions of the classic pathway in normolipemic xanthoma planum with IgG1 monoclonal immunoglobulins (6 cases)].
Kövary PM, Cassuto JP, Dujardin P, Maiolini R, Campagni JP, Herzberg JJ, Schwartzkopff W, Gebhart W, Audoly P.
Rev Med Interne. 1981 Oct;2(3):275-9. doi: 10.1016/s0248-8663(81)80026-4.
